Trials / Unknown
UnknownNCT00525967
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain: A Randomized, Double-Blind Study
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Faculdade de Medicina do ABC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether oral methadone plus acetaminophen can substitute morphine in the treatment of cancer pain.
Detailed description
Opioids are the mainstay of moderate-to-severe cancer pain management. Although morphine is the most commonly used, methadone has some advantages such as higher potency, lower cost and longer administration intervals. To minimize the time necessary to achieve the equianalgesic effect after a switching from morphine to methadone, acetaminophen was added in the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methadone plus Acetaminophen or Placebo | Methadone bid according to a established conversion morphine-to-methadone ratio plus Placebo or Acetaminophen qid |
Timeline
- Start date
- 2006-02-01
- Completion
- 2007-10-01
- First posted
- 2007-09-06
- Last updated
- 2007-09-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00525967. Inclusion in this directory is not an endorsement.